Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
‘Not time to give up’ on tau protein therapeutics, expert says
SEATTLE — Although successful tau therapeutics have not yet been identified, new insights into the protein’s biology may soon lead to treatments, according to a presenter at the 2022 American Academy of Neurology annual meeting.
Zolpidem may be effective for prolonged disorders of consciousness
SEATTLE — The use of 30 mg per day of zolpidem may significantly improve quality of life among patients with prolonged disorders of consciousness, a presenter said at the 2022 American Academy of Neurology annual meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Full recovery from disorders of consciousness possible after severe COVID-19 infection
SEATTLE — Full recovery and functional independence is possible in patients who experience a disorder of consciousness after severe COVID-19 infection, according to a presenter at the 2022 American Academy of Neurology annual meeting.
VIDEO: Sage Therapeutics plans Alzheimer’s disease trial
SEATTLE — Sage Therapeutics will be starting a randomized, controlled trial in patients with Alzheimer’s disease, Aaron Koenig, MD, the company’s vice president of early clinical development, said at the 2022 American Academy of Neurology annual meeting.
Symptom overlap: Challenging diagnoses in pediatric neurology
SEATTLE — Sarah J. Spence, MD, PhD, shared tips on differentiating pediatric neurological conditions with overlapping symptoms, at the 2022 American Academy of Neurology annual meeting.
Mobile units improve outcomes in patients with acute ischemic stroke
SEATTLE — Mobile stroke units were linked with improved outcomes compared with conventional emergency medical services for people with acute ischemic stroke, a presenter said at the 2022 American Academy of Neurology annual meeting.
Gamma sensory stimulation safe, effective in those with Alzheimer’s disease
SEATTLE — Self-administered home use of gamma sensory stimulation reduced brain atrophy safely in people with Alzheimer’s disease, a presenter said at the 2022 American Academy of Neurology annual meeting.
COVID-19 led to unprecedented decline in global life expectancy
The COVID-19 pandemic reduced the world’s life expectancy by about 2 years, according to recent estimates published in Population and Development Review.
Persistent cognitive impairment after mild COVID infection linked to CSF inflammation
SEATTLE — People with persistent cognitive symptoms after mild COVID-19 infection had elevated cerebrospinal fluid inflammatory markers, according to a presentation at the 2022 American Academy of Neurology annual meeting.
Endovascular brain-computer implant safe, effective for patients with paralysis
SEATTLE — In a first-in-human study, participants with paralysis who received an endovascular brain-computer implant were able to effectively operate a computer, researchers reported at the American Academy of Neurology annual meeting.
-
Headline News
Advances in life expectancy have slowed, with major gains ‘implausible in this century’
October 07, 20243 min read -
Headline News
Four children's hospitals claim top spots in U.S. News & World Report ranking
October 08, 20242 min read -
Headline News
FDA reviewing application for bemotrizinol as first new sunscreen ingredient since 1999
October 07, 20241 min read
-
Headline News
Advances in life expectancy have slowed, with major gains ‘implausible in this century’
October 07, 20243 min read -
Headline News
Four children's hospitals claim top spots in U.S. News & World Report ranking
October 08, 20242 min read -
Headline News
FDA reviewing application for bemotrizinol as first new sunscreen ingredient since 1999
October 07, 20241 min read